Literature DB >> 30429570

Building a better lymphoma vaccine.

Claire Ainsworth.   

Abstract

Entities:  

Keywords:  Cancer; Drug discovery; Therapeutics; Vaccines

Mesh:

Substances:

Year:  2018        PMID: 30429570     DOI: 10.1038/d41586-018-07366-1

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  3 in total

Review 1.  The risk of developing multiple sclerosis in individuals seronegative for Epstein-Barr virus: a meta-analysis.

Authors:  Julia Pakpoor; Giulio Disanto; Jennifer E Gerber; Ruth Dobson; Ute C Meier; Gavin Giovannoni; Sreeram V Ramagopalan
Journal:  Mult Scler       Date:  2012-06-11       Impact factor: 6.312

2.  Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation.

Authors:  C M Rooney; C A Smith; C Y Ng; S Loftin; C Li; R A Krance; M K Brenner; H E Heslop
Journal:  Lancet       Date:  1995-01-07       Impact factor: 79.321

3.  Rational Design of an Epstein-Barr Virus Vaccine Targeting the Receptor-Binding Site.

Authors:  Masaru Kanekiyo; Wei Bu; M Gordon Joyce; Geng Meng; James R R Whittle; Ulrich Baxa; Takuya Yamamoto; Sandeep Narpala; John-Paul Todd; Srinivas S Rao; Adrian B McDermott; Richard A Koup; Michael G Rossmann; John R Mascola; Barney S Graham; Jeffrey I Cohen; Gary J Nabel
Journal:  Cell       Date:  2015-08-13       Impact factor: 41.582

  3 in total
  4 in total

1.  Neutralizing Antibodies Protect against Oral Transmission of Lymphocryptovirus.

Authors:  Swati Singh; Leah J Homad; Nicholas R Akins; Claire M Stoffers; Stefan Lackhar; Harman Malhi; Yu-Hsin Wan; David J Rawlings; Andrew T McGuire
Journal:  Cell Rep Med       Date:  2020-06-23

2.  Modelling the dynamics of EBV transmission to inform a vaccine target product profile and future vaccination strategy.

Authors:  Lara Goscé; Joanne R Winter; Graham S Taylor; Joanna E A Lewis; Helen R Stagg
Journal:  Sci Rep       Date:  2019-06-26       Impact factor: 4.379

3.  Childcare attendance and risk of infectious mononucleosis: A population-based Danish cohort study.

Authors:  Klaus Rostgaard; Lone Graff Stensballe; Signe Holst Søegaard; Mads Kamper-Jørgensen; Henrik Hjalgrim
Journal:  PLoS One       Date:  2021-12-22       Impact factor: 3.240

4.  Immunization with a self-assembling nanoparticle vaccine displaying EBV gH/gL protects humanized mice against lethal viral challenge.

Authors:  Harman Malhi; Leah J Homad; Yu-Hsin Wan; Bibhav Poudel; Brooke Fiala; Andrew J Borst; Jing Yang Wang; Carl Walkey; Jason Price; Abigail Wall; Suruchi Singh; Zoe Moodie; Lauren Carter; Simran Handa; Colin E Correnti; Barry L Stoddard; David Veesler; Marie Pancera; James Olson; Neil P King; Andrew T McGuire
Journal:  Cell Rep Med       Date:  2022-06-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.